04R34KZ
Replacement Hepatic Artery to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 4 Lower Arteries |
| Operation | R Replacement |
| Body Part | 3 Hepatic Artery |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
Replacement procedures in the lower arteries involve taking out a diseased or damaged arterial segment and putting in synthetic graft material or biological tissue to physically stand in for that piece of vessel. This is distinct from simply patching or reinforcing an artery, since the native segment is functionally substituted rather than preserved and bolstered.
A classic example is an aortobifemoral or femoral-popliteal graft placed after removing a severely diseased, occluded, or aneurysmal segment of artery, using a synthetic conduit such as Dacron or PTFE, or in some cases a harvested vein used as a full segmental replacement. Patients typically arrive at this procedure after conservative management or angioplasty has failed, or when an aneurysm poses a rupture risk that mandates excising the weakened wall.
Anatomy & Axis Detail
Hepatic Artery
The hepatic artery, typically the common or proper hepatic artery branching from the celiac trunk, is the primary arterial supply to the liver and is critical in liver transplantation, where donor and recipient vessels must be joined, as well as in resection for tumors involving the porta hepatis. Replacement is performed when the native artery is aneurysmal, dissected, injured, or must be divided and reconstructed to accommodate tumor clearance or transplant anastomosis, using either a segment of donor vessel, autologous conduit, or synthetic graft. Because hepatic arterial flow is essential to bile duct viability and liver perfusion, even brief interruption carries meaningful risk, and reconstruction technique is closely tied to outcomes. Operative reports should be reviewed to distinguish anastomotic reconstruction during transplantation from replacement performed for isolated arterial disease.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
The operative report must clearly establish that a segment of native artery was excised or its function replaced, and that a graft or biological material took its place, distinguishing this from Bypass, where the diseased segment is left in place and a new route is constructed around it. Coders should identify the specific arterial body part value replaced and the device value representing the graft material, whether autologous, nonautologous, or synthetic.
A common error is coding a bypass graft as a Replacement when the original artery segment was left intact and simply routed around; another is failing to capture the correct device value when a combination of graft materials was used in a single reconstruction.